Drop in Pfizer's efficacy in Israel against Delta variant is NOTHING to worry ...

Drop in Pfizer's efficacy in Israel against Delta variant is NOTHING to worry ...
Drop in Pfizer's efficacy in Israel against Delta variant is NOTHING to worry ...

There is no reason to worry about Israel downgrading the efficacy of Pfizer's Covid vaccine against the Indian variant, experts say.

Israeli health chiefs now claim the jab blocks 64 per cent of infections, compared to 94 per cent in May before the mutant strain took hold. Ministers described the data as 'disturbing'.

But scientists today attempted to quash any fears about the vaccine efficacy, saying overall the picture was still 'reassuring'. 

The same statistics showed the jab still protects against serious illness, slashing the risk of being hospitalised by 93 per cent. For comparison, Israeli news website Ynet reported the figure in May was slightly above the 98 per cent mark. 

Health chiefs there now claim the jab blocks 64 per cent of infections, compared to 94 per cent in May before the mutant strain took hold. Ministers reportedly described the data 'disturbing'. But the same statistics showed the jab still protects against serious illness, slashing the risk of being hospitalised by 93 per cent

Health chiefs there now claim the jab blocks 64 per cent of infections, compared to 94 per cent in May before the mutant strain took hold. Ministers reportedly described the data 'disturbing'. But the same statistics showed the jab still protects against serious illness, slashing the risk of being hospitalised by 93 per cent

Pfizer's Covid vaccine was up to a third less effective against the Indian 'Delta' variant, according to data from Israel (stock)

Pfizer's Covid vaccine was up to a third less effective against the Indian 'Delta' variant, according to data from Israel (stock)

Vaccine gap cut from 12 weeks to eight for EVERY adult as No10 vows to offer two jabs to all over-18s by mid-September

Britons under the age of 40 will be offered their second Covid jab after eight weeks instead of 12.

Boris Johnson claimed the new aim was for all adults to be fully inoculated by mid-September, when coronavirus rates are expected to rise and the NHS grapples with seasonal winter pressures.

Last month, the gap was shortened for older people in a bid to protect millions of the most vulnerable amid the rise of the highly-infectious Indian variant.

The Prime Minister announced the change to the dosing strategy at tonight's press conference, where he set out plans for a post-lockdown England from July 19.

Ministers are also considering whether to roll out third vaccines for all over-50s, NHS staff, carers and patients with underlying health conditions this autumn.

Oxford University researchers last week showed antibody levels could be restored to their peak with the use of a 'booster' vaccine months after the second.

But whether or not this would improve on the already near-100 per cent protection against death that two doses provide is still unknown.

No10 is now wrestling with the moral dilemma of whether to run the booster vaccine programme or send the doses to developing countries where supplies are scarce.

Vaccinating children is another contentious strategy being considered by the Government, with some of its advisers warning that Covid itself is less dangerous to youngsters than a jab.

Advertisement

Dr Bharat Pankhania, an infectious disease expert at the University of Exeter, said the data reflects a normal drop in immunity rates over time. 

He told MailOnline: 'The good news is people are still protected and the vaccines are preventing hospitalisations, so there are lots of positives.'

Professor Andrew Preston, a University of Bath microbiologist, told MailOnline: 'The important thing is this relatively low value is against transmission of the virus and not deaths as such.

'We have not

read more from dailymail.....

NEXT Female teacher, 35, is arrested after sending nude pics via text to students ... trends now